86.22.Z - Specialist medical practice activities
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
63.12.Z - Web portals
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.21.Z - General medical practice activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | 0 | 0 | -65,3 |
EBITDA | -0 | 0,1 | 0,1 | -30,2 |
Short time liabilities | 1,2 | 1 | 1,2 | 15,2 |
Equity capital | -0,5 | -0,5 | -0,5 | 6,6 |
Operating profit (EBIT) | -0,1 | 0 | 0 | -61,5 |
Assets | 0,8 | 0,6 | 0,8 | 31,7 |
Net profit (loss) | -0,1 | 0 | 0 | -65,3 |
Cash | 0,2 | 0 | 0 | -81,6 |
Net income from sale | 1,1 | 1,3 | 1,7 | 31,3 |
Liabilities and provisions for liabilities | 1,3 | 1,1 | 1,3 | 14,7 |
Working assets | 0,5 | 0,5 | 0,6 | 20,4 |
Depreciation | 0,1 | 0,1 | 0,1 | -13,1 |
% | % | % | p.p. | |
Profitability of capital | 21,9 | -8,5 | -3,2 | 5,3 |
Equity capital to total assets | -70,8 | -79,9 | -56,6 | 23,3 |
Gross profit margin | -10,7 | 3,3 | 0,9 | -2,4 |
EBITDA Margin | -1,1 | 10,7 | 5,7 | -5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 391 | 292 | 256 | -36 |
Current financial liquidity indicator | 0.44262459874153137 | 0.4603636562824249 | 0.4813159704208374 | 0 |
Net dept to EBITDA | -55.504337310791016 | 4.8164567947387695 | 8.090829849243164 | 3,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane